University of Oxford and Oracle Cloud System Helping Researchers Identify COVID-19 Variants Faster
Retrieved on:
Monday, September 20, 2021
Cloud, Policy, CTO, Delta, SP3, Tony Blair Institute for Global Change, University, Virus, Oracle Corporation, Program, Pathology, Java, Safety, Laboratory, Industry, Southwest Border Security Consortium, Global Health, Old Road Campus, Multimedia, Heart, CEO, Divisions of the University of Oxford, Coronavirus, TBI, Oracle Cloud, Variant of concern, NYSE, Global change, Oxford Nanopore Technologies, Solution, Institute, MySQL, Microbiology, Face, Severe acute respiratory syndrome coronavirus 2, Organization, OCI, Oxford University Innovation, Time, Nuffield Department of Population Health, Oracle Application Express, COVID-19, Public health, View, Research, University of Oxford, Lawrence, Pharmaceutical industry, Vaccine, Medical device, Software
Uniting governments and medical communities in this challenge, the University of Oxford and Oracle's Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.
Key Points:
- Uniting governments and medical communities in this challenge, the University of Oxford and Oracle's Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.
- The Global Pathogen Analysis System is being provided as a free resource to help combat COVID-19 and other microbial health threats.
- Researchers are using the system to upload pathogen data and receive comprehensive results within minutes.
- Oracle offersintegrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud.For more information about Oracle (NYSE: ORCL), please visit us at oracle.com .